GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Epitomee Medical Ltd (XTAE:EPIT) » Definitions » NonCurrent Deferred Liabilities

Epitomee Medical (XTAE:EPIT) NonCurrent Deferred Liabilities : ₪0.00 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Epitomee Medical NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Epitomee Medical's non-current deferred liabilities for the quarter that ended in Dec. 2023 was ₪0.00 Mil.

Epitomee Medical NonCurrent Deferred Liabilities Historical Data

The historical data trend for Epitomee Medical's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epitomee Medical NonCurrent Deferred Liabilities Chart

Epitomee Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial - - - - -

Epitomee Medical Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only - - - - -

Epitomee Medical NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Epitomee Medical's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Epitomee Medical (XTAE:EPIT) Business Description

Traded in Other Exchanges
Address
Tarshish 19, Caesarea, ISR, 3088900
Epitomee Medical Ltd is engaged in developing and commercializing ingestible therapeutic devices.

Epitomee Medical (XTAE:EPIT) Headlines

No Headlines